These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 24227857)

  • 1. Differential impact of magnitude, polyfunctional capacity, and specificity of HIV-specific CD8+ T cell responses on HIV set point.
    Riou C; Burgers WA; Mlisana K; Koup RA; Roederer M; Abdool Karim SS; Williamson C; Gray CM
    J Virol; 2014 Feb; 88(3):1819-24. PubMed ID: 24227857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominant HIV-specific CD8+ T-cell responses are common to blood and gastrointestinal mucosa, and Gag-specific responses dominate in rectal mucosa of HIV controllers.
    Ferre AL; Lemongello D; Hunt PW; Morris MM; Garcia JC; Pollard RB; Yee HF; Martin JN; Deeks SG; Shacklett BL
    J Virol; 2010 Oct; 84(19):10354-65. PubMed ID: 20668079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.
    Perdiguero B; Gómez CE; Cepeda V; Sánchez-Sampedro L; García-Arriaza J; Mejías-Pérez E; Jiménez V; Sánchez C; Sorzano CÓ; Oliveros JC; Delaloye J; Roger T; Calandra T; Asbach B; Wagner R; Kibler KV; Jacobs BL; Pantaleo G; Esteban M
    J Virol; 2015 Jan; 89(2):970-88. PubMed ID: 25355891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyfunctional analysis of Gag and Nef specific CD8+ T-cell responses in HIV-1 infected Indian individuals.
    Mendiratta S; Vajpayee M; Mojumdar K; Chauhan NK; Sreenivas V
    Vaccine; 2011 Feb; 29(6):1150-8. PubMed ID: 21172377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of polyfunctional HIV-specific T cells upon stimulation with mRNA electroporated dendritic cells in the presence of immunomodulatory drugs.
    De Keersmaecker B; Allard SD; Lacor P; Schots R; Thielemans K; Aerts JL
    J Virol; 2012 Sep; 86(17):9351-60. PubMed ID: 22718823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Gag immunodominance of the HIV-specific T-cell response during acute/early infection is associated with higher CD8+ T-cell antiviral activity and correlates with preservation of the CD4+ T-cell compartment.
    Turk G; Ghiglione Y; Falivene J; Socias ME; Laufer N; Coloccini RS; Rodriguez AM; Ruiz MJ; Pando MÁ; Giavedoni LD; Cahn P; Sued O; Salomon H; Gherardi MM
    J Virol; 2013 Jul; 87(13):7445-62. PubMed ID: 23616666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-specific CD8+ T cell responses to HXB2 Gag and Nef peptide pools in Chinese HIV/AIDS patients.
    Zhang H; Qiu Z; Jiao Y; Wang A; Li T
    Sci China C Life Sci; 2009 Sep; 52(9):841-6. PubMed ID: 19802743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
    Huang XL; Fan Z; Borowski L; Rinaldo CR
    Clin Vaccine Immunol; 2009 Oct; 16(10):1504-16. PubMed ID: 19692626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Broad and persistent Gag-specific CD8+ T-cell responses are associated with viral control but rarely drive viral escape during primary HIV-1 infection.
    Radebe M; Gounder K; Mokgoro M; Ndhlovu ZM; Mncube Z; Mkhize L; van der Stok M; Jaggernath M; Walker BD; Ndung'u T
    AIDS; 2015 Jan; 29(1):23-33. PubMed ID: 25387316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short conserved sequences of HIV-1 are highly immunogenic and shift immunodominance.
    Yang OO; Ali A; Kasahara N; Faure-Kumar E; Bae JY; Picker LJ; Park H
    J Virol; 2015 Jan; 89(2):1195-204. PubMed ID: 25378501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-cell level response of HIV-specific and cytomegalovirus-specific CD4 T cells correlate with viral control in chronic HIV-1 subtype A infection.
    Eller MA; Eller LA; Ratto-Kim S; Ouma BJ; Lo V; de Souza M; Guwatudde D; Nails B; Michael NL; Wabwire-Mangen F; Robb ML; Marovich MA; Sandberg JK; Currier JR
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):9-18. PubMed ID: 22580564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral activity of human immunodeficiency virus type 1 Gag-specific cytotoxic T lymphocyte targeting is not necessarily intrinsically superior to envelope targeting.
    Chen DY; Balamurugan A; Ng HL; Yang OO
    J Virol; 2011 Mar; 85(5):2474-8. PubMed ID: 21159882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Gag and Nef-specific ELISpot-based CTL responses in HIV-1 infected Indian individuals.
    Mendiratta S; Vajpayee M; Malhotra U; Kaushik S; Dar L; Mojumdar K; Chauhan NK; Sreenivas V
    Med Microbiol Immunol; 2009 Feb; 198(1):47-56. PubMed ID: 18985383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altering an artificial Gagpolnef polyprotein and mode of ENV co-administration affects the immunogenicity of a clade C HIV DNA vaccine.
    Böckl K; Wild J; Bredl S; Kindsmüller K; Köstler J; Wagner R
    PLoS One; 2012; 7(4):e34723. PubMed ID: 22509350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Gag- and Env-Specific CD8+ T Cell Responses in ART-Naïve HIV-Infected Patients: Potential Implications for Individualized Immunotherapy.
    Prebensen C; Lind A; Dyrhol-Riise AM; Kvale D
    PLoS One; 2016; 11(4):e0153849. PubMed ID: 27128502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential Gag-specific polyfunctional T cell maturation patterns in HIV-1 elite controllers.
    Ferrando-Martínez S; Casazza JP; Leal M; Machmach K; Muñoz-Fernández MÁ; Viciana P; Koup RA; Ruiz-Mateos E
    J Virol; 2012 Apr; 86(7):3667-74. PubMed ID: 22278254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.
    Arrode G; Hegde R; Jin Y; Singh DK; Narayan O; Chebloune Y
    Vaccine; 2008 Jul; 26(31):3795-804. PubMed ID: 18586360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Killed whole-HIV vaccine; employing a well established strategy for antiviral vaccines.
    Kang CY; Gao Y
    AIDS Res Ther; 2017 Sep; 14(1):47. PubMed ID: 28893272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.